Chenlu Zhang

20 Xisi Road
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.

Journal: Technology in cancer research & treatment
Published: January 31, 2022

The role of cystatin C as a proteasome inhibitor in multiple myeloma.

The role of cystatin C as a proteasome inhibitor in multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands)
Published: November 30, 2020

lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway.

lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway.

Journal: Oncology letters
Published: July 31, 2020

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.

Journal: Aging
Published: March 12, 2020

Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis.

Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis.

Journal: Translational cancer research
Published: December 13, 2019

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: OncoTargets and therapy
Published: November 12, 2019

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy.

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy.

Journal: OncoTargets and therapy
Published: July 18, 2019

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.

Journal: BMC cancer
Published: January 03, 2019
Showing 1-8 of 8

Last Updated: 09/26/2026